Qube Research & Technologies (QRT)’s ClearPoint Neuro CLPT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-163,014	Closed	-$1.94M	–	3590
2025 Q1	$1.94M	Sell	163,014 -71,474	-30%	-$1.11M	﹤0.01%	1965
2024 Q4	$3.61M	Buy	234,488 +110,031	+88%	+$1.43M	﹤0.01%	1644
2024 Q3	$1.4M	Buy	124,457 +72,668	+140%	+$696K	﹤0.01%	1906
2024 Q2	$279K	Buy	+51,789	New	+$300K	﹤0.01%	2334
2023 Q2	–	Sell	-50,327	Closed	-$425K	–	2463
2023 Q1	$425K	Buy	50,327 +22,059	+78%	+$193K	﹤0.01%	1614
2022 Q4	$239K	Buy	28,268 +12,657	+81%	+$120K	﹤0.01%	1734
2022 Q3	$162K	Buy	15,611 +3,830	+33%	+$50.5K	﹤0.01%	1832
2022 Q2	$154K	Buy	+11,781	New	+$120K	﹤0.01%	1800
2021 Q3	–	Sell	-17,019	Closed	-$325K	–	2272
2021 Q2	$325K	Buy	17,019 +6,581	+63%	+$127K	﹤0.01%	1526
2021 Q1	$221K	Buy	+10,438	New	+$223K	﹤0.01%	1613

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLPT Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of ClearPoint Neuro (CLPT) in Q2 2025, closing a stake of 163,014 shares — an estimated $1.94M sold.

Qube Research & Technologies (QRT) first reported a position in CLPT in Q1 2021 and held it in 10 quarters. The position peaked at $3.61M in Q4 2024. 96 funds tracked by Wall St. Rank hold CLPT as of Q2 2025.

Qube Research & Technologies (QRT) reported no remaining ClearPoint Neuro position as of Q2 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 163,014 ClearPoint Neuro shares in Q2 2025, an estimated $1.94M.
Qube Research & Technologies (QRT) first reported a position in ClearPoint Neuro in Q1 2021 and held it in 10 quarters.
Qube Research & Technologies (QRT)'s ClearPoint Neuro position peaked at $3.61M in Q4 2024.
96 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.